BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 10805089)

  • 1. Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein.
    Probst A; Götz J; Wiederhold KH; Tolnay M; Mistl C; Jaton AL; Hong M; Ishihara T; Lee VM; Trojanowski JQ; Jakes R; Crowther RA; Spillantini MG; Bürki K; Goedert M
    Acta Neuropathol; 2000 May; 99(5):469-81. PubMed ID: 10805089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo analysis of wild-type and FTDP-17 tau transgenic mice.
    Götz J; Barmettler R; Ferrari A; Goedert M; Probst A; Nitsch RM
    Ann N Y Acad Sci; 2000; 920():126-33. PubMed ID: 11193141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice.
    Leroy K; Bretteville A; Schindowski K; Gilissen E; Authelet M; De Decker R; Yilmaz Z; Buée L; Brion JP
    Am J Pathol; 2007 Sep; 171(3):976-92. PubMed ID: 17690183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein.
    Lewis J; McGowan E; Rockwood J; Melrose H; Nacharaju P; Van Slegtenhorst M; Gwinn-Hardy K; Paul Murphy M; Baker M; Yu X; Duff K; Hardy J; Corral A; Lin WL; Yen SH; Dickson DW; Davies P; Hutton M
    Nat Genet; 2000 Aug; 25(4):402-5. PubMed ID: 10932182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive white matter pathology in the spinal cord of transgenic mice expressing mutant (P301L) human tau.
    Lin WL; Zehr C; Lewis J; Hutton M; Yen SH; Dickson DW
    J Neurocytol; 2005 Dec; 34(6):397-410. PubMed ID: 16902761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform.
    Ishihara T; Hong M; Zhang B; Nakagawa Y; Lee MK; Trojanowski JQ; Lee VM
    Neuron; 1999 Nov; 24(3):751-62. PubMed ID: 10595524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein.
    Spittaels K; Van den Haute C; Van Dorpe J; Bruynseels K; Vandezande K; Laenen I; Geerts H; Mercken M; Sciot R; Van Lommel A; Loos R; Van Leuven F
    Am J Pathol; 1999 Dec; 155(6):2153-65. PubMed ID: 10595944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced visualization of axonopathy in EAE using thy1-YFP transgenic mice.
    Bannerman PG; Hahn A
    J Neurol Sci; 2007 Sep; 260(1-2):23-32. PubMed ID: 17493638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein.
    Giasson BI; Duda JE; Quinn SM; Zhang B; Trojanowski JQ; Lee VM
    Neuron; 2002 May; 34(4):521-33. PubMed ID: 12062037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein.
    Allen B; Ingram E; Takao M; Smith MJ; Jakes R; Virdee K; Yoshida H; Holzer M; Craxton M; Emson PC; Atzori C; Migheli A; Crowther RA; Ghetti B; Spillantini MG; Goedert M
    J Neurosci; 2002 Nov; 22(21):9340-51. PubMed ID: 12417659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modest loss of peripheral axons, muscle atrophy and formation of brain inclusions in mice with targeted deletion of gigaxonin exon 1.
    Dequen F; Bomont P; Gowing G; Cleveland DW; Julien JP
    J Neurochem; 2008 Oct; 107(1):253-64. PubMed ID: 18680552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of Parkin enhances nigrostriatal and motor neuron lesion in mice over-expressing human-mutated tau protein.
    Menéndez J; Rodríguez-Navarro JA; Solano RM; Casarejos MJ; Rodal I; Guerrero R; Sánchez MP; Avila J; Mena MA; de Yébenes JG
    Hum Mol Genet; 2006 Jul; 15(13):2045-58. PubMed ID: 16698879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuated neurodegenerative disease phenotype in tau transgenic mouse lacking neurofilaments.
    Ishihara T; Higuchi M; Zhang B; Yoshiyama Y; Hong M; Trojanowski JQ; Lee VM
    J Neurosci; 2001 Aug; 21(16):6026-35. PubMed ID: 11487626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau inclusions in retinal ganglion cells of human P301S tau transgenic mice: effects on axonal viability.
    Gasparini L; Crowther RA; Martin KR; Berg N; Coleman M; Goedert M; Spillantini MG
    Neurobiol Aging; 2011 Mar; 32(3):419-33. PubMed ID: 19356824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau isoforms expression in transgenic mouse model of amyotrophic lateral sclerosis.
    Usarek E; Kuźma-Kozakiewicz M; Schwalenstöcker B; Kaźmierczak B; Münch C; Ludolph AC; Barańczyk-Kuźma A
    Neurochem Res; 2006 May; 31(5):597-602. PubMed ID: 16770730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic mouse models of tauopathies: prospects for animal models of Pick's disease.
    Lee VM; Trojanowski JQ
    Neurology; 2001 Jun; 56(11 Suppl 4):S26-30. PubMed ID: 11402147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tau gene mutation G389R causes a tauopathy with abundant pick body-like inclusions and axonal deposits.
    Murrell JR; Spillantini MG; Zolo P; Guazzelli M; Smith MJ; Hasegawa M; Redi F; Crowther RA; Pietrini P; Ghetti B; Goedert M
    J Neuropathol Exp Neurol; 1999 Dec; 58(12):1207-26. PubMed ID: 10604746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperphosphorylated tau aggregates in the cortex and hippocampus of transgenic mice with mutant human FTDP-17 Tau and lacking the PARK2 gene.
    Guerrero R; Navarro P; Gallego E; Garcia-Cabrero AM; Avila J; Sanchez MP
    Acta Neuropathol; 2009 Feb; 117(2):159-68. PubMed ID: 19057915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in gracile axonal dystrophy mice.
    Mi W; Beirowski B; Gillingwater TH; Adalbert R; Wagner D; Grumme D; Osaka H; Conforti L; Arnhold S; Addicks K; Wada K; Ribchester RR; Coleman MP
    Brain; 2005 Feb; 128(Pt 2):405-16. PubMed ID: 15644421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive Motor Deficit is Mediated by the Denervation of Neuromuscular Junctions and Axonal Degeneration in Transgenic Mice Expressing Mutant (P301S) Tau Protein.
    Yin Z; Valkenburg F; Hornix BE; Mantingh-Otter I; Zhou X; Mari M; Reggiori F; Van Dam D; Eggen BJL; De Deyn PP; Boddeke E
    J Alzheimers Dis; 2017; 60(s1):S41-S57. PubMed ID: 28222529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.